menu
    • menu

    Company profile for Epsilogen

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Epsilogen is a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer. IgE has several key features that make it ideal for the treatment of solid tumours including greater potency, enhanced tumour access and a long tissue half-life. The epsilon constant region of IgE binds very tightly to its cognate receptor (FcεRI) on the surface of immune effector cells including macrophages, monocytes, basop...
    Epsilogen is a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer. IgE has several key features that make it ideal for the treatment of solid tumours including greater potency, enhanced tumour access and a long tissue half-life. The epsilon constant region of IgE binds very tightly to its cognate receptor (FcεRI) on the surface of immune effector cells including macrophages, monocytes, basophils and eosinophils. This interaction is up to 10,000 fold greater than the gamma chain of IgG has for its equivalent receptor.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Epsilogenunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    London BioScience Innovation Centre, 2 Royal College Street, London NW1 0NH
    Telephone
    Telephone
    +44 (0) 203 657 7612
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://epsilogen.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Epsilogen Names Cristina Oliva, MD, Phd Chief Medical Officer
    Epsilogen Names Cristina Oliva, MD, Phd Chief Medical Officer

    07 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-07/epsilogen-announces-the-appointment-of-cristina-oliva-md-phd-as-chief-medical-officer

    PHARMIWEB
    07 Oct 2025
    Share Share
    UK's Epsilogen acquires fellow immunoglobin biotech TigaTx
    UK's Epsilogen acquires fellow immunoglobin biotech TigaTx

    08 Apr 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/uks-epsilogen-acquires-fellow-immunoglobin-biotech-tigatx-expand-cancer-antibody-options

    FIERCE BIOTECH
    08 Apr 2025
    Share Share
    Epsilogen Acquires TigaTx, Inc. to Create Leading Cancer Antibody
    Epsilogen Acquires TigaTx, Inc. to Create Leading Cancer Antibody

    07 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250406268542/en/Epsilogen-Announces-Acquisition-of-TigaTx-Inc.-to-Create-Worlds-Leading-Pan-Isotype-Cancer-Antibody-Company

    BUSINESSWIRE
    07 Apr 2025
    Share Share
    Epsilogen Announces Initiation of Phase Ib Trial of MOv18 IgE
    Epsilogen Announces Initiation of Phase Ib Trial of MOv18 IgE

    02 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241202478799/en

    BUSINESSWIRE
    02 Dec 2024
    Share Share
    Epsilogen Completes £12.5 Million Series B Financing Expansion
    Epsilogen Completes £12.5 Million Series B Financing Expansion

    09 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240908069943/en

    BUSINESSWIRE
    09 Sep 2024
    Share Share
    Epsilogen's MOv18 IgE CTA Approved For Phase Ib In Resistant Ovarian Cancer
    Epsilogen's MOv18 IgE CTA Approved For Phase Ib In Resistant Ovarian Cancer

    08 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240707808760/en

    BUSINESSWIRE
    08 Jul 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search